LARIMAR THERAPEUTICS INC. - COMMON STOCK
3.6600
10-1月-25 15:45:00
15 分の遅延
株式
-0.1300
-3.43%
本日の幅
3.5800 - 3.7500
ISIN
N/A
ソース
NASDAQ
-
Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
10 8 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
17 7 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Set to Join Russell 3000® Index
21 6 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
28 3 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
14 3 2023 06:00:01 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
07 2 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
21 11 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
10 11 2022 06:00:04 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
07 11 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
20 10 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
19 10 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
16 9 2022 12:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
14 9 2022 06:04:00 提供 Nasdaq GlobeNewswire
-
14 9 2022 06:01:00 提供 Nasdaq GlobeNewswire
-
28 7 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
28 6 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Scientific Conference Presentations
02 6 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
19 5 2022 07:00:01 提供 Nasdaq GlobeNewswire